Eli Lilly attempts to block Sun Pharma's generic Strattera

09/25/2007 | Business Standard (India)

Eli Lilly & Co. has filed a patent infringement suit against Sun Pharmaceutical Industries, which seeks to produce and sell a generic version of Lilly's attention deficit hyperactivity disorder drug Strattera. In a complaint filed Sept. 20, Eli Lilly said the company would be "irreparably harmed" by the FDA's approval of Sun's request.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ